Renee P. Tannenbaum, Director at ANI PHARMACEUTICALS INC (ANIP), sold 2,000 shares at $63.87 ($128K) on 2024-05-16, disclosed to the SEC on 2024-05-17.
Open-market sale of $128k ANIP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRDF | BUY | 2022-09-19 | $17K | — | Filing → |
| ZGNX | SELL | 2021-11-30 | $124K | — | Filing → |
| ZGNX | BUY | 2021-06-03 | $85K | — | Filing → |